KB111 topical gel for Hailey-Hailey disease
Part of Genetic & congenital, Skin clinical trials.
This trial tests a new topical gel called KB111 for treating Hailey-Hailey disease, a genetic skin condition that causes painful blisters. The study will check if the gel is safe and helps reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Hailey-Hailey disease with a genetic test result
- You are 12 years old or older
- You are not pregnant or breastfeeding
- If you are taking medications for the condition, you must be on a stable dose for at least 1 month before starting and during the 12-week study
- You must agree to use effective birth control from the first dose until 3 months after the last dose
- You cannot have any other skin or health condition that might interfere with the study treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the drug guselkumab to see if it can help control Hailey-Hailey disease, a rare skin condition. If you have moderate-to-severe HHD affecting multiple body areas, you may be able to join.
This trial tests an investigational gel called HW211026 for people with actinic keratosis, a common precancerous skin condition. It aims to see if the gel is a safe and effective treatment for lesions on the face.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This trial tests a new gene therapy called BD111 for people with a herpes simplex virus infection in the cornea (the clear front part of the eye). It aims to see if the treatment is safe and can help clear the virus, possibly improving vision.
This trial tests a new drug called Brivekimig for people with moderate to severe hidradenitis suppurativa (HS) who have not gotten enough relief from oral antibiotics. The goal is to see if it can reduce abscesses and inflamed bumps.
This study tests a new ointment (HL-300) designed to treat mild-to-moderate atopic dermatitis (a chronic skin condition causing itching and inflammation). You would apply it to affected skin areas to see if it safely reduces symptoms.
Hear when a new Skin Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.